SK281446B6 - Heterocyklylbenzoylguanidín, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje - Google Patents
Heterocyklylbenzoylguanidín, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje Download PDFInfo
- Publication number
- SK281446B6 SK281446B6 SK1029-95A SK102995A SK281446B6 SK 281446 B6 SK281446 B6 SK 281446B6 SK 102995 A SK102995 A SK 102995A SK 281446 B6 SK281446 B6 SK 281446B6
- Authority
- SK
- Slovakia
- Prior art keywords
- diaminomethylene
- formula
- group
- methylsulfonylbenzamide
- methyl ester
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/68—One oxygen atom attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Furan Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4430861A DE4430861A1 (de) | 1994-08-31 | 1994-08-31 | Heterocyclyl-benzoylguanidine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK102995A3 SK102995A3 (en) | 1996-06-05 |
| SK281446B6 true SK281446B6 (sk) | 2001-03-12 |
Family
ID=6526985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1029-95A SK281446B6 (sk) | 1994-08-31 | 1995-08-21 | Heterocyklylbenzoylguanidín, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5753680A (es) |
| EP (1) | EP0699666B1 (es) |
| JP (1) | JP4023841B2 (es) |
| KR (1) | KR100375788B1 (es) |
| CN (1) | CN1058004C (es) |
| AT (1) | ATE175406T1 (es) |
| AU (1) | AU702258B2 (es) |
| BR (1) | BR9503881A (es) |
| CA (1) | CA2157146C (es) |
| CZ (1) | CZ286400B6 (es) |
| DE (2) | DE4430861A1 (es) |
| DK (1) | DK0699666T3 (es) |
| ES (1) | ES2129716T3 (es) |
| GR (1) | GR3029894T3 (es) |
| HU (1) | HUT73183A (es) |
| NO (1) | NO305798B1 (es) |
| PL (1) | PL183393B1 (es) |
| RU (1) | RU2152390C1 (es) |
| SK (1) | SK281446B6 (es) |
| TW (1) | TW354783B (es) |
| UA (1) | UA35609C2 (es) |
| ZA (1) | ZA957284B (es) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4328352A1 (de) * | 1993-08-24 | 1995-03-02 | Hoechst Ag | Substituierte N,N'-Di-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| ZA967800B (en) * | 1995-09-20 | 1997-04-03 | Yamanouchi Pharma Co Ltd | Heteroaryllsubstituted acryloylguanidine derivatives and pharmaceutical compositions comprising them |
| DE19601303A1 (de) * | 1996-01-16 | 1997-07-17 | Boehringer Ingelheim Kg | Neuartige Benzoylguanidin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln |
| NZ314105A (en) * | 1996-02-02 | 1997-12-19 | Sumitomo Pharma | Guanidine derivative substituted with a substituted indole which is peri condensed with a heterocyclic ring |
| DE19608161A1 (de) | 1996-03-04 | 1997-09-11 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19608162A1 (de) * | 1996-03-04 | 1997-09-11 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19624178A1 (de) * | 1996-06-18 | 1998-01-08 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| EP0972767A4 (en) * | 1997-03-06 | 2000-05-24 | Toa Eiyo Ltd | CYCLOALCA [b] PYRIDINE-3-CARBONYLGUANIDINE DERIVATIVES, THEIR PRODUCTION PROCESS AND MEDICAMENTS CONTAINING THEM |
| DE19738604A1 (de) * | 1997-09-04 | 1999-03-11 | Hoechst Marion Roussel De Gmbh | Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verminderung der Giftigkeit cardiotoxischer Stoffe |
| DE19833118C2 (de) * | 1998-07-23 | 2000-07-27 | Merck Patent Gmbh | Verfahren zur Herstellung von orthoalkylierten Benzoesäurederivaten |
| CZ20011785A3 (cs) * | 1998-11-26 | 2001-10-17 | Merck Patent Gmbh | Pouľití benzoylguanidinů pro oąetřování diabetes mellitus nezávislého na inzulínu |
| DE19859727A1 (de) * | 1998-12-23 | 2000-06-29 | Aventis Pharma Gmbh | Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung |
| DE19903275A1 (de) * | 1999-01-28 | 2000-08-03 | Merck Patent Gmbh | Lyophilisate mit verbesserter Rekonstituierbarkeit |
| DE19919349A1 (de) * | 1999-04-28 | 2000-11-02 | Merck Patent Gmbh | Verfahren zur Herstellung eines Benzoylguanidinderivates |
| DE19929857A1 (de) * | 1999-06-29 | 2001-01-04 | Merck Patent Gmbh | Verfahren zur Herstellung eines 4-(Pyrrol-1-yl)-benzoylguanidinderivates |
| DE19950898A1 (de) | 1999-10-22 | 2001-04-26 | Aventis Pharma Gmbh | Heterocyclisch substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE10001879A1 (de) * | 2000-01-19 | 2001-07-19 | Aventis Pharma Gmbh | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| IL147696A0 (en) * | 2001-01-25 | 2002-08-14 | Pfizer Prod Inc | Combination therapy |
| EP2174932B1 (en) * | 2003-03-13 | 2019-07-03 | Idemitsu Kosan Co., Ltd. | Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same |
| US7629493B2 (en) * | 2003-05-06 | 2009-12-08 | Merck Patent Gmbh | Process for the crystallisation of guandinium salts |
| KR100658698B1 (ko) * | 2004-12-27 | 2006-12-19 | 한국화학연구원 | 벤조싸이오펜-2-카르보닐구아니딘 유도체, 이의 제조방법및 이를 포함하는 약학적 조성물 |
| CN101119971B (zh) * | 2005-02-16 | 2010-09-08 | 东亚荣养株式会社 | 环庚[b]吡啶-3-羰基胍衍生物及含有该衍生物的医药品 |
| CN100371328C (zh) * | 2006-01-19 | 2008-02-27 | 中国药科大学 | 取代苯甲酰基胍衍生物、其制备方法及其医药用途 |
| US20110118262A1 (en) * | 2008-07-08 | 2011-05-19 | Boehringer Ingelheim International Gmbh | Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3929582A1 (de) * | 1989-09-06 | 1991-03-07 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament |
| CZ284456B6 (cs) * | 1992-02-15 | 1998-12-16 | Hoechst Aktiengesellschaft | Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje |
| ATE139526T1 (de) * | 1992-02-15 | 1996-07-15 | Hoechst Ag | 3,5-substituierte benzoylguanidine, mit antiarrythmischer wirkung und inhibierender wirkung auf die proliferationen von zellen |
| DE59307360D1 (de) * | 1992-02-15 | 1997-10-23 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4328869A1 (de) * | 1993-08-27 | 1995-03-02 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4404183A1 (de) * | 1994-02-10 | 1995-08-17 | Merck Patent Gmbh | 4-Amino-1-piperidylbenzoylguanidine |
-
1994
- 1994-08-31 DE DE4430861A patent/DE4430861A1/de not_active Withdrawn
-
1995
- 1995-07-21 TW TW084107588A patent/TW354783B/zh active
- 1995-08-21 SK SK1029-95A patent/SK281446B6/sk unknown
- 1995-08-23 UA UA95083918A patent/UA35609C2/uk unknown
- 1995-08-24 DE DE59504721T patent/DE59504721D1/de not_active Expired - Lifetime
- 1995-08-24 ES ES95113307T patent/ES2129716T3/es not_active Expired - Lifetime
- 1995-08-24 EP EP95113307A patent/EP0699666B1/de not_active Expired - Lifetime
- 1995-08-24 AU AU30250/95A patent/AU702258B2/en not_active Ceased
- 1995-08-24 DK DK95113307T patent/DK0699666T3/da active
- 1995-08-24 AT AT95113307T patent/ATE175406T1/de not_active IP Right Cessation
- 1995-08-29 CZ CZ19952202A patent/CZ286400B6/cs not_active IP Right Cessation
- 1995-08-29 CA CA002157146A patent/CA2157146C/en not_active Expired - Fee Related
- 1995-08-30 NO NO953404A patent/NO305798B1/no not_active IP Right Cessation
- 1995-08-30 CN CN95116901A patent/CN1058004C/zh not_active Expired - Fee Related
- 1995-08-30 PL PL95310224A patent/PL183393B1/pl not_active IP Right Cessation
- 1995-08-30 RU RU95114847/04A patent/RU2152390C1/ru not_active IP Right Cessation
- 1995-08-30 ZA ZA957284A patent/ZA957284B/xx unknown
- 1995-08-30 HU HU9502548A patent/HUT73183A/hu unknown
- 1995-08-30 US US08/520,780 patent/US5753680A/en not_active Expired - Lifetime
- 1995-08-31 JP JP24515195A patent/JP4023841B2/ja not_active Expired - Fee Related
- 1995-08-31 BR BR9503881A patent/BR9503881A/pt not_active Application Discontinuation
- 1995-08-31 KR KR1019950027957A patent/KR100375788B1/ko not_active IP Right Cessation
-
1999
- 1999-04-07 GR GR990400985T patent/GR3029894T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO953404D0 (no) | 1995-08-30 |
| HUT73183A (en) | 1996-06-28 |
| JPH0873427A (ja) | 1996-03-19 |
| CN1126720A (zh) | 1996-07-17 |
| US5753680A (en) | 1998-05-19 |
| TW354783B (en) | 1999-03-21 |
| DE59504721D1 (de) | 1999-02-18 |
| GR3029894T3 (en) | 1999-07-30 |
| DK0699666T3 (da) | 1999-08-30 |
| EP0699666A1 (de) | 1996-03-06 |
| CN1058004C (zh) | 2000-11-01 |
| NO953404L (no) | 1996-03-01 |
| HU9502548D0 (en) | 1995-10-30 |
| RU2152390C1 (ru) | 2000-07-10 |
| SK102995A3 (en) | 1996-06-05 |
| CZ286400B6 (en) | 2000-04-12 |
| AU702258B2 (en) | 1999-02-18 |
| CZ220295A3 (en) | 1996-08-14 |
| NO305798B1 (no) | 1999-07-26 |
| UA35609C2 (uk) | 2001-04-16 |
| AU3025095A (en) | 1996-03-14 |
| KR960007564A (ko) | 1996-03-22 |
| ZA957284B (en) | 1996-04-02 |
| ES2129716T3 (es) | 1999-06-16 |
| EP0699666B1 (de) | 1999-01-07 |
| DE4430861A1 (de) | 1996-03-07 |
| PL183393B1 (pl) | 2002-06-28 |
| PL310224A1 (en) | 1996-03-04 |
| KR100375788B1 (ko) | 2003-07-18 |
| CA2157146C (en) | 2007-05-22 |
| JP4023841B2 (ja) | 2007-12-19 |
| ATE175406T1 (de) | 1999-01-15 |
| CA2157146A1 (en) | 1996-03-01 |
| BR9503881A (pt) | 1996-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK281446B6 (sk) | Heterocyklylbenzoylguanidín, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje | |
| SK15795A3 (en) | 4-amino-1-piperidylbenzoylguanides their using, method of their production, pharmaceutical preparations on their base and method of their production | |
| SK103396A3 (en) | Sulfonylbenzoyl guanidine or sulfinylbenzoyl guanidine derivative, manufacturing process thereof and pharmaceutical compositions containing them | |
| KR100406687B1 (ko) | 알킬벤조일구아니딘유도체 | |
| SK59096A3 (en) | Benzoylguanidine derivative containing fluor, preparation method thereof and pharmaceutical composition containing them | |
| SK281135B6 (sk) | Derivát arylbenzoylguanidínu, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje | |
| RU2160728C2 (ru) | 4-амино-бензоилгуанидины, способы их получения, фармацевтическая композиция и способ ингибирования целлюлярного na+/h+-антипортера | |
| SK12896A3 (en) | Derivatives of 4-mercaptobenzoylguanidine, substituted at ortho-position, preparation method and pharmaceutical compositions containing them | |
| RU2160732C2 (ru) | Гетероциклилокси-бензоилгуанидины, способы их получения, их фармацевтическая композиция и способ ее получения | |
| SK281363B6 (sk) | Derivát alkyl-5-metylsulfonylbenzoguanidínu, spôsob jeho prípravy a farmaceutický prostriedok, ktorý ho obsahuje |